Amoaku, W
Cackett, P
Tyagi, A
Mahmood, U
Nosek, J
Mennie, G
Rumney, N
Article History
First Online: 10 July 2014
Change Date: 11 September 2014
Change Type: Erratum
Change Details: Correction to: Eye (2014) 28, S1–S10; doi:10.1038/eye.2014.125 Since the publication of the above article, it has been noted that the incorrect Creative Commons License logo and text were given. The details are given below. In addition, the Open logo was missing from above the article title on the first page.
Competing interests
: Winfried Amoaku has received honoraria for participation in advisory board meetings sponsored by Alcon, Allergan, Novartis, and Thrombogenics, for presentations sponsored by Alcon, Alimera Science, Allergan, Novartis, and Thrombogenics, and holds research grants from Allergan and Novartis. Peter Cackett has received honoraria for participation in advisory board meetings sponsored by Alcon, Bayer, and Novartis, and from Novartis for presentations. Ajai Tyagi has received honoraria for participating in advisory boards and speaking engagements sponsored by Alcon, and his employer has received a grant from Alcon. Usman Mahmood declares no conflict of interest. Jennifer Nosek has received honoraria for participation in advisory board meetings sponsored by Alcon, Alimera Science, Bayer, and Novartis. Graham Mennie has received honoraria for participation in advisory board meetings sponsored by Alcon, Bayer, and Novartis. Nicholas Rumney has received an honorarium for participation in an advisory board meeting sponsored by Alcon.